MEDTRONIC PLC (MDT) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:MDT • IE00BTN1Y115

103.18 USD
+0.47 (+0.46%)
At close: Feb 3, 2026
103.36 USD
+0.18 (+0.17%)
After Hours: 2/3/2026, 4:31:13 PM
Fundamental Rating

6

MDT gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 186 industry peers in the Health Care Equipment & Supplies industry. While MDT belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. MDT has a correct valuation and a medium growth rate. Finally MDT also has an excellent dividend rating. These ratings would make MDT suitable for dividend investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year MDT was profitable.
  • MDT had a positive operating cash flow in the past year.
  • Each year in the past 5 years MDT has been profitable.
  • Each year in the past 5 years MDT had a positive operating cash flow.
MDT Yearly Net Income VS EBIT VS OCF VS FCFMDT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

1.2 Ratios

  • With an excellent Return On Assets value of 5.22%, MDT belongs to the best of the industry, outperforming 82.26% of the companies in the same industry.
  • MDT has a Return On Equity of 9.79%. This is amongst the best in the industry. MDT outperforms 86.02% of its industry peers.
  • With an excellent Return On Invested Capital value of 6.63%, MDT belongs to the best of the industry, outperforming 81.18% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for MDT is below the industry average of 8.80%.
  • The last Return On Invested Capital (6.63%) for MDT is above the 3 year average (6.35%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.22%
ROE 9.79%
ROIC 6.63%
ROA(3y)4.43%
ROA(5y)4.54%
ROE(3y)8.11%
ROE(5y)8.19%
ROIC(3y)6.35%
ROIC(5y)6.24%
MDT Yearly ROA, ROE, ROICMDT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8

1.3 Margins

  • MDT has a better Profit Margin (13.71%) than 90.86% of its industry peers.
  • In the last couple of years the Profit Margin of MDT has declined.
  • MDT has a Operating Margin of 19.42%. This is amongst the best in the industry. MDT outperforms 93.01% of its industry peers.
  • In the last couple of years the Operating Margin of MDT has remained more or less at the same level.
  • With a decent Gross Margin value of 65.57%, MDT is doing good in the industry, outperforming 70.43% of the companies in the same industry.
  • MDT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 19.42%
PM (TTM) 13.71%
GM 65.57%
OM growth 3Y-3.47%
OM growth 5Y0.37%
PM growth 3Y-4.39%
PM growth 5Y-3.44%
GM growth 3Y-1.55%
GM growth 5Y-0.76%
MDT Yearly Profit, Operating, Gross MarginsMDT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MDT is destroying value.
  • MDT has less shares outstanding than it did 1 year ago.
  • MDT has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, MDT has a worse debt to assets ratio.
MDT Yearly Shares OutstandingMDT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
MDT Yearly Total Debt VS Total AssetsMDT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B

2.2 Solvency

  • An Altman-Z score of 3.15 indicates that MDT is not in any danger for bankruptcy at the moment.
  • With a decent Altman-Z score value of 3.15, MDT is doing good in the industry, outperforming 69.89% of the companies in the same industry.
  • The Debt to FCF ratio of MDT is 5.59, which is a neutral value as it means it would take MDT, 5.59 years of fcf income to pay off all of its debts.
  • MDT has a better Debt to FCF ratio (5.59) than 78.49% of its industry peers.
  • A Debt/Equity ratio of 0.57 indicates that MDT is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.57, MDT is not doing good in the industry: 60.75% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 5.59
Altman-Z 3.15
ROIC/WACC0.96
WACC6.94%
MDT Yearly LT Debt VS Equity VS FCFMDT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.3 Liquidity

  • MDT has a Current Ratio of 2.42. This indicates that MDT is financially healthy and has no problem in meeting its short term obligations.
  • MDT has a Current ratio (2.42) which is in line with its industry peers.
  • A Quick Ratio of 1.80 indicates that MDT should not have too much problems paying its short term obligations.
  • MDT has a Quick ratio (1.80) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.42
Quick Ratio 1.8
MDT Yearly Current Assets VS Current LiabilitesMDT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

4

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 7.24% over the past year.
  • Measured over the past 5 years, MDT shows a small growth in Earnings Per Share. The EPS has been growing by 3.68% on average per year.
  • The Revenue has been growing slightly by 5.34% in the past year.
  • The Revenue has been growing slightly by 3.01% on average over the past years.
EPS 1Y (TTM)7.24%
EPS 3Y-0.72%
EPS 5Y3.68%
EPS Q2Q%7.94%
Revenue 1Y (TTM)5.34%
Revenue growth 3Y1.91%
Revenue growth 5Y3.01%
Sales Q2Q%6.64%

3.2 Future

  • Based on estimates for the next years, MDT will show a small growth in Earnings Per Share. The EPS will grow by 6.08% on average per year.
  • Based on estimates for the next years, MDT will show a small growth in Revenue. The Revenue will grow by 5.80% on average per year.
EPS Next Y3.62%
EPS Next 2Y6.02%
EPS Next 3Y6.42%
EPS Next 5Y6.08%
Revenue Next Year7.67%
Revenue Next 2Y6.75%
Revenue Next 3Y6.25%
Revenue Next 5Y5.8%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MDT Yearly Revenue VS EstimatesMDT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B 40B
MDT Yearly EPS VS EstimatesMDT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 18.33 indicates a rather expensive valuation of MDT.
  • 83.87% of the companies in the same industry are more expensive than MDT, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 28.41. MDT is valued slightly cheaper when compared to this.
  • Based on the Price/Forward Earnings ratio of 16.69, the valuation of MDT can be described as correct.
  • Based on the Price/Forward Earnings ratio, MDT is valued cheaply inside the industry as 86.02% of the companies are valued more expensively.
  • MDT's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.64.
Industry RankSector Rank
PE 18.33
Fwd PE 16.69
MDT Price Earnings VS Forward Price EarningsMDT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, MDT is valued cheaper than 82.26% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of MDT indicates a rather cheap valuation: MDT is cheaper than 83.87% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 25.41
EV/EBITDA 14.89
MDT Per share dataMDT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The excellent profitability rating of MDT may justify a higher PE ratio.
PEG (NY)5.06
PEG (5Y)4.98
EPS Next 2Y6.02%
EPS Next 3Y6.42%

7

5. Dividend

5.1 Amount

  • MDT has a Yearly Dividend Yield of 2.81%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 0.21, MDT pays a better dividend. On top of this MDT pays more dividend than 98.39% of the companies listed in the same industry.
  • MDT's Dividend Yield is rather good when compared to the S&P500 average which is at 1.83.
Industry RankSector Rank
Dividend Yield 2.81%

5.2 History

  • The dividend of MDT has a limited annual growth rate of 5.10%.
  • MDT has paid a dividend for at least 10 years, which is a reliable track record.
  • MDT has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)5.1%
Div Incr Years11
Div Non Decr Years11
MDT Yearly Dividends per shareMDT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

  • 75.86% of the earnings are spent on dividend by MDT. This is not a sustainable payout ratio.
  • MDT's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP75.86%
EPS Next 2Y6.02%
EPS Next 3Y6.42%
MDT Yearly Income VS Free CF VS DividendMDT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B
MDT Dividend Payout.MDT Dividend Payout, showing the Payout Ratio.MDT Dividend Payout.PayoutRetained Earnings

MEDTRONIC PLC

NYSE:MDT (2/3/2026, 4:31:13 PM)

After market: 103.36 +0.18 (+0.17%)

103.18

+0.47 (+0.46%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-18
Earnings (Next)02-17
Inst Owners88.22%
Inst Owner Change-1.8%
Ins Owners0.28%
Ins Owner Change-1.4%
Market Cap132.28B
Revenue(TTM)34.76B
Net Income(TTM)4.76B
Analysts74.21
Price Target111.71 (8.27%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.81%
Yearly Dividend2.77
Dividend Growth(5Y)5.1%
DP75.86%
Div Incr Years11
Div Non Decr Years11
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.96%
Min EPS beat(2)1.49%
Max EPS beat(2)2.43%
EPS beat(4)4
Avg EPS beat(4)1.68%
Min EPS beat(4)1.21%
Max EPS beat(4)2.43%
EPS beat(8)6
Avg EPS beat(8)1.26%
EPS beat(12)9
Avg EPS beat(12)1.96%
EPS beat(16)10
Avg EPS beat(16)1.24%
Revenue beat(2)2
Avg Revenue beat(2)0.49%
Min Revenue beat(2)0.08%
Max Revenue beat(2)0.91%
Revenue beat(4)3
Avg Revenue beat(4)-0.06%
Min Revenue beat(4)-1.38%
Max Revenue beat(4)0.91%
Revenue beat(8)7
Avg Revenue beat(8)0.29%
Revenue beat(12)10
Avg Revenue beat(12)0.59%
Revenue beat(16)11
Avg Revenue beat(16)-0.1%
PT rev (1m)-0.48%
PT rev (3m)8.45%
EPS NQ rev (1m)0.01%
EPS NQ rev (3m)-0.91%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)0.29%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)0.49%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)0.6%
Valuation
Industry RankSector Rank
PE 18.33
Fwd PE 16.69
P/S 3.81
P/FCF 25.41
P/OCF 18.6
P/B 2.72
P/tB N/A
EV/EBITDA 14.89
EPS(TTM)5.63
EY5.46%
EPS(NY)6.18
Fwd EY5.99%
FCF(TTM)4.06
FCFY3.94%
OCF(TTM)5.55
OCFY5.38%
SpS27.11
BVpS37.95
TBVpS-3.06
PEG (NY)5.06
PEG (5Y)4.98
Graham Number69.34
Profitability
Industry RankSector Rank
ROA 5.22%
ROE 9.79%
ROCE 8.29%
ROIC 6.63%
ROICexc 7.39%
ROICexgc 26.33%
OM 19.42%
PM (TTM) 13.71%
GM 65.57%
FCFM 14.98%
ROA(3y)4.43%
ROA(5y)4.54%
ROE(3y)8.11%
ROE(5y)8.19%
ROIC(3y)6.35%
ROIC(5y)6.24%
ROICexc(3y)7.09%
ROICexc(5y)7.05%
ROICexgc(3y)29.85%
ROICexgc(5y)33.32%
ROCE(3y)7.94%
ROCE(5y)7.8%
ROICexgc growth 3Y-11.61%
ROICexgc growth 5Y-5.52%
ROICexc growth 3Y-2.49%
ROICexc growth 5Y3.26%
OM growth 3Y-3.47%
OM growth 5Y0.37%
PM growth 3Y-4.39%
PM growth 5Y-3.44%
GM growth 3Y-1.55%
GM growth 5Y-0.76%
F-Score8
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 5.59
Debt/EBITDA 2.83
Cap/Depr 63.21%
Cap/Sales 5.49%
Interest Coverage 8.53
Cash Conversion 72.83%
Profit Quality 109.28%
Current Ratio 2.42
Quick Ratio 1.8
Altman-Z 3.15
F-Score8
WACC6.94%
ROIC/WACC0.96
Cap/Depr(3y)59.68%
Cap/Depr(5y)55.94%
Cap/Sales(3y)5.04%
Cap/Sales(5y)4.79%
Profit Quality(3y)124.85%
Profit Quality(5y)125.74%
High Growth Momentum
Growth
EPS 1Y (TTM)7.24%
EPS 3Y-0.72%
EPS 5Y3.68%
EPS Q2Q%7.94%
EPS Next Y3.62%
EPS Next 2Y6.02%
EPS Next 3Y6.42%
EPS Next 5Y6.08%
Revenue 1Y (TTM)5.34%
Revenue growth 3Y1.91%
Revenue growth 5Y3.01%
Sales Q2Q%6.64%
Revenue Next Year7.67%
Revenue Next 2Y6.75%
Revenue Next 3Y6.25%
Revenue Next 5Y5.8%
EBIT growth 1Y7.35%
EBIT growth 3Y-1.62%
EBIT growth 5Y3.4%
EBIT Next Year17.96%
EBIT Next 3Y11.21%
EBIT Next 5Y9.23%
FCF growth 1Y28.67%
FCF growth 3Y-4.64%
FCF growth 5Y-2.95%
OCF growth 1Y27.68%
OCF growth 3Y-1.39%
OCF growth 5Y-0.53%

MEDTRONIC PLC / MDT FAQ

What is the fundamental rating for MDT stock?

ChartMill assigns a fundamental rating of 6 / 10 to MDT.


What is the valuation status for MDT stock?

ChartMill assigns a valuation rating of 6 / 10 to MEDTRONIC PLC (MDT). This can be considered as Fairly Valued.


What is the profitability of MDT stock?

MEDTRONIC PLC (MDT) has a profitability rating of 8 / 10.


What is the valuation of MEDTRONIC PLC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for MEDTRONIC PLC (MDT) is 18.33 and the Price/Book (PB) ratio is 2.72.


What is the earnings growth outlook for MEDTRONIC PLC?

The Earnings per Share (EPS) of MEDTRONIC PLC (MDT) is expected to grow by 3.62% in the next year.